Preventive examination:

• Postmenopausal women with risk factors (e.g. early menopause, low weight).
• Men with risk factors (e.g. smoking, chronic diseases).
• People undergoing long-term hormone therapy, have a hereditary predisposition, consume insufficient amounts of calcium, and lead a sedentary lifestyle.

Suspected osteoporosis:

• Fractures with minor trauma, especially in people over 50 years of age. This may indicate a decrease in bone density and an increased risk of osteoporosis.
• A decrease in height of more than 2.5 cm, which may indicate spinal fractures.
• Chronic back pain involving spinal compression fractures.

Long-term therapy that affects bone tissue:

• Taking glucocorticosteroids for more than three months.
• Treatment with anticoagulants (e.g. heparin).
• Prolonged use of anticonvulsants or drugs that suppress estrogen production.

Chronic diseases affecting bone metabolism:

• Thyroid or parathyroid diseases.
• Diabetes mellitus, rheumatoid arthritis.
• Chronic kidney or liver diseases.
• Malabsorption (celiac disease, Crohn's disease).

Monitoring the effectiveness of osteoporosis treatment:

• Assessment of changes in bone mineral density during therapy.

People who are deficient in vitamin D or calcium

• A lack of vitamin D and calcium in the body can accelerate bone loss, so densitometry helps assess bone condition in these patients.

Smoking and alcohol abuse

• Smokers and people who abuse alcohol have a higher risk of decreased bone density.

Absolute contraindications:

• Pregnancy (especially during the first trimester).

Relative contraindications:

• Recent radiopaque examination or radioisotope scan (within the past 2-3 weeks).
• Metal implants or endoprostheses in the test area that may distort the results.
• Obesity, significantly exceeding the capabilities of the device (usually more than 120-130 kg).